medigraphic.com
ISSN 1405-8871 (Print)

2017, Number 3

<< Back Next >>

Aten Fam 2017; 24 (3)

Clinical Inertia in Patients with Diabetes Mellitus type 2 in a Family Medicine Unit in Acapulco Guerrero, Mexico

García-Morales G, Reyes-Jiménez M

Language: Spanish
References: 22
Page: 102-106
PDF size: 200.04 Kb.


ABSTRACT

Objective: to determine the clinical inertia in patients with diabetes mellitus type 2. Methods: analytical and cross-sectional study from July to December 2016. It included 345 patients who attended consultation in the Family Medicine Unit no. 26 in Acapulco, Guerrero, Mexico, who presented a diagnosis of diabetes mellitus type 2. Some figures of blood pressure, weight and body mass index were taken from their clinical records; glucose, cholesterol, triglycerides and creatinine from the laboratory tests. The medical notes were analyzed, after the laboratory tests, and it was assessed if the doctor established any change in the management of patients where there was lack of metabolic control. Results: of the 345 surveyed patients, 288 (83.47%) showed lack of control in some metabolic variable; 33 patients (9.6%) had uncontrolled blood pressure; 156 (45.2%) were overweight; 199 (57.7%) there was uncontrolled glycemic; 111 (32.2%) had figures of total cholesterol higher than 200 mg/dl; in 192 (55.7%) triglycerides were higher than 150 mg/dl; and four (1.2%) had less than 15ml/min/1.73m2 glomerular filtration. It was determined clinical inertia in 103 patients (35.8%) with metabolic disorder. Conclusion: the majority of the analyzed patients in this study presented lack of control in some metabolic variable, while clinical inertia was applied to one of every three patients with metabolic disorder. Educational and intervention strategies should be generated in order to mitigate these problems in the Family Physician clinical work.


REFERENCES

  1. Federación Internacional de Diabetes. Atlas de la Diabetes de la FID [Internet]. 2014; 6ª ed. [Citado 2017 marzo]. Disponible en: http:// www.idf.org/diabetesatlas

  2. Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine. 2014;42(12):698-702.

  3. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Informe Final de Resultados. Cuernavaca, México: Instituto Nacional de Salud Pública; 2016.

  4. Rodríguez-Ábrego G, Escobedo-de la Peña J, Zurita B, Ramírez TJ. Muerte prematura y discapacidad en los derechohabientes del Instituto Mexicano del Seguro Social. Salud Pública Mex. 2007;49:132-43.

  5. Arredondo A, De Icaza E. Costos de la Diabetes en América Latina: Evidencias del Caso Mexicano. Value Health. 2011;14(5 Suppl 1):S85-8.

  6. Rodríguez-Bolaños RA, Reynales-Shigematsu LM, Jiménez-Ruiz JA, Juárez-Márquez SA, Hernández-Ávila M. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de microcosteo. Rev Panam Salud Pública. 2010;28(6):412- 20.

  7. 7- American Diabetes Association. Standards of medical care in diabetes - 2014. Diabetes Care. 2014;37(S1):S14-S80.

  8. Pérez-Cuevas R, Doubova SV, Suarez-Ortega M, Law M, Pande AH, Escobedo J, et al. Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico. bmc Medical informatics and decision making. 2012;12(1):50.

  9. González-Clemente JM, Font B, Lahoz R, Llaurado G, Gambus G. Inercia clínica en pacientes con diabetes mellitus tipo 2 no insulinizados en tratamiento con hipoglucemiantes orales. Med Clin. 2014;142(11):478-84.

  10. Aujoulat I, Jacquemin P, Hermans MP, Rietzschel E, Scheen A, Trefois P, et al. Clinical inertia in general practice, a matter of debate: a qualitative study with 114 general practitioners in Belgium. bmc Family Practice. 2015;16(1):1-13.

  11. Brach WT, Higgins S. Inercia Clínica: la dificultad de superarla. Rev Esp Cardiolo. 2010;63(12):1399-401.

  12. López-Simarro F. Inercia Terapéutica. Causas y soluciones. Hipertens riesgo vasc. 2012;29(supl 1):S28-33.

  13. Strain WD, Cos X, Hirst M, Venancio S, Mohan V, Voko Z, et al. Time to do more: Addressing clinical inertia in the management of type 2 diabetes mellitus. Diabetes Res Clin Pract. 2014;105(3):302-12.

  14. Mata-Cases M. Inercia terapéutica en el control glucémico de la diabetes mellitus tipo 2: inconvenientes y ventajas. Hipertens riesgo vasc. 2012;29(Supl1):34-40.

  15. Aujoulat I, Jacquemin P, Rietzschel E, Scheen A, Trefois P, Wens J, et al. Factors associated with clinical inertia: an integrative review. Adv Med Educ Pract. 2014;5:141-7.

  16. Martell-Claros N, Franch J. Inercia e incumplimiento a partes iguales. Hipertens riesgo vasc. 2012;29(Supl 1):1-3.

  17. López-Simarro F. Inercia terapéutica en diabetes. Diabetes practice. 2014;5(2):49-96.

  18. O’Connor PJ. Improving diabetes care by combating clinical inertia. Health Serv Res. 2005;40:1854-61.

  19. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical Inertia. Ann Intern Med. 2001;135(9):825-34.

  20. imss. Guía de Práctica Clínica Tratamiento de la Diabetes Mellitus Tipo 2 en el Primer Nivel de Atención. México: Instituto Mexicano del Seguro Social; 2014.

  21. Jasso-Huamán LE, Villena-Pacheco A, Guevara- Linares X. Control metabólico en pacientes diabéticos ambulatorios de un Hospital General. Rev Med Hered. 2015;26:167-72.

  22. López-Simarro F, Brotons C, Moral I, Cols Sagarra C, Selva A, Aguado-Jodar A, et al. Inercia y cumplimiento terapéutico en pacientes con diabetes mellitus tipo 2 en atención primaria. Med Clin. 2012;138(9):377-84.




2020     |     www.medigraphic.com